SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today announced the release of the latest versions of its VIA™ and Solve™ software for genomic data analysis and ...
The global peptide microarray market share analysis is on a steady growth trajectory, projected to reach USD 903.8 million by 2025, with a compound annual growth rate (CAGR) of 3.8%. By 2035, the ...
AZoLifeSciences on MSN
Microarray Profiling Identifies LINC00974 as a Sensitive Marker for Breast Cancer Risk
In the post-genomic era, long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cancers and hold potential as minimally invasive diagnostic biomarkers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback